Response to comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530

Diabetes

Volumn 61, Issue 9, 2012, Pages

  Froguel, Philippe ^a,b   Marquez, Marcel ^a   Cauchi, Stéphane ^a  

^a Institut Pasteur de Lille   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GENOMIC DNA;

DISEASE PREDISPOSITION; FAMILY HISTORY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HIGH MOBILITY GROUP A1A PROTEIN GENE; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; HMGA1A PROTEIN; HUMANS;

EID: 84865516469     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0800     Document Type: Letter

References (10)

1. Brunetti A, Chiefari E, Pullinger CR, et al. Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530 (Letter). Diabetes 2012;61:e3. DOI: 10.2337/db12-0051
2. Marquez M, Huyvaert M, Perry JR, et al.; DIAGRAM Consortium. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530
3. Chiefari E, Tanyolaç S, Paonessa F, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 2011;305:903-912
4. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885
5. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345 (Pubitemid 46871655)
6. Zeggini E, Weedon MN, Lindgren CM, et al.; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-1341 (Pubitemid 46871654)
7. Saxena R, Voight BF, Lyssenko V, et al.; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes for BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336
8. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007;39:770-775 (Pubitemid 46848592)
9. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators;; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
10. Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false-but a little replication goes a long way. PLoS Med 2007;4:e28